Larry Todd Edwards insider trades

Open-market stock purchases and sales by Larry Todd Edwards, Chief Commercial Officer at Oruka Therapeutics, Inc, from SEC Form 4 filings since Sep 27, 2023.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +199%.

Recent trades

DateStockTradeValue
Aug 24, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
Aug 24, 2026ORKA Oruka Therapeutics, IncBought (not open market)—
Mar 2, 2026ARQT Arcutis Biotherapeutics, IncSold$90.2K
Mar 2, 2026ARQT Arcutis Biotherapeutics, IncSold$2.7K
Feb 27, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Feb 27, 2026ARQT Arcutis Biotherapeutics, IncBought (not open market)—
Feb 2, 2026ARQT Arcutis Biotherapeutics, IncSold$52.3K
Nov 6, 2025ARQT Arcutis Biotherapeutics, IncSold$733K
Oct 2, 2025ARQT Arcutis Biotherapeutics, IncSold$84.1K
Oct 2, 2025ARQT Arcutis Biotherapeutics, IncSold$6.2K

Companies traded

  • ORKA Oruka Therapeutics, Inc: other filings, last Aug 24, 2026
  • ARQT Arcutis Biotherapeutics, Inc: 1 buy, 10 sales, last Mar 2, 2026

Get free alerts when Larry Todd Edwards files a new trade →